Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3.17M
-
Shares change
-
-5.31M
-
Total reported value, excl. options
-
$3.77M
-
Value change
-
-$5.15M
-
Number of buys
-
21
-
Number of sells
-
-10
-
Price
-
$1.19
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2022
45 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q3 2022.
Summit Therapeutics Inc. - COM (SMMT) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.17M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (776K shares), MILLENNIUM MANAGEMENT LLC (432K shares), BlackRock Inc. (421K shares), MORGAN STANLEY (351K shares), GEODE CAPITAL MANAGEMENT, LLC (324K shares), MARSHALL WACE, LLP (141K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (89.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (81.7K shares), GOLDMAN SACHS GROUP INC (60.7K shares), and UBS Group AG (49.2K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.